Recombinant multi-species RORA protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RORA protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a member of the NR1 subfamily of nuclear hormone receptors. It can bind as a monomer or as a homodimer to hormone response elements upstream of several genes to enhance the expression of those genes. The encoded protein has been shown to interact with NM23-2, a nucleoside diphosphate kinase involved in organogenesis and differentiation, as well as with NM23-1, the product of a tumor metastasis suppressor candidate gene. Also, it has been shown to aid in the transcriptional regulation of some genes involved in circadian rhythm. Four transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Feb 2014]
The Alternative Names of target: RORA,Nuclear receptor ROR-alpha,Nuclear receptor RZR-alpha, Nuclear receptor subfamily 1 group F member 1, RAR-related orphan receptor A, Retinoid-related orphan receptor-alpha,ROR1,ROR2,ROR3,RZRA,NR1F1,RORa1,IDDECA,RORalpha,RZR-ALPHA
Go
to RORA products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T43206-Ab-1/ GM-Tg-hg-T43206-Ab-2 | Human RORA protein | Human |
GM-Tg-rg-T43206-Ab-1/ GM-Tg-rg-T43206-Ab-2 | Rat RORA protein | Rat |
GM-Tg-mg-T43206-Ab-1/ GM-Tg-mg-T43206-Ab-2 | Mouse RORA protein | Mouse |
GM-Tg-cynog-T43206-Ab-1/ GM-Tg-cynog-T43206-Ab-2 | Cynomolgus/Rhesus macaque RORA monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T43206-Ab-1/ GM-Tg-felg-T43206-Ab-2 | Feline RORA protein | Feline |
GM-Tg-cang-T43206-Ab-1/ GM-Tg-cang-T43206-Ab-2 | Canine RORA protein | Canine |
GM-Tg-bovg-T43206-Ab-1/ GM-Tg-bovg-T43206-Ab-2 | Bovine RORA protein | Bovine |
GM-Tg-equg-T43206-Ab-1/ GM-Tg-equg-T43206-Ab-2 | Equine RORA protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. |
GM-Tg-hg-T43206-Ab-1/ GM-Tg-hg-T43206-Ab-2;
GM-Tg-rg-T43206-Ab-1/ GM-Tg-rg-T43206-Ab-2;
GM-Tg-mg-T43206-Ab-1/ GM-Tg-mg-T43206-Ab-2; GM-Tg-cynog-T43206-Ab-1/ GM-Tg-cynog-T43206-Ab-2; GM-Tg-felg-T43206-Ab-1/ GM-Tg-felg-T43206-Ab-2; GM-Tg-cang-T43206-Ab-1/ GM-Tg-cang-T43206-Ab-2; GM-Tg-bovg-T43206-Ab-1/ GM-Tg-bovg-T43206-Ab-2; GM-Tg-equg-T43206-Ab-1/ GM-Tg-equg-T43206-Ab-2 |
Products Name | RORA protein |
Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
Target Name | RORA |
Protein Sub-location | Introcelluar Protein |
Isotypes | Recombinant protein |
Expression platform | Mammalian cell |
Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
Tag | His |
Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RORA protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab
GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.